Firms Must Be Proactive About Live-Case Demo Plans For IDE Devices – FDA Draft Guidance
This article was originally published in The Gray Sheet
FDA has released a draft guidance on the information that a device manufacturer should submit in an investigational device exemption application or supplement if it wants the device to be part of a live case demonstration.
You may also be interested in...
New final guidance from the US FDA sets out the agency’s expectations for the use of live-case presentations during device clinical trials, focusing on patient protection.
Interventional cardiologists presented new data at the annual meeting of The Society for Cardiovascular Angiography and Interventions supporting the safe use of live video transmission of transcatheter aortic valve replacement cases, and results from other late-breaking clinical trials.
The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.